首頁 > 市場調查報告書 > 醫療設備

心血管設備

動脈切開封堵器市場規模、佔有率、成長分析（按產品、應用、最終用戶、地區）- 產業預測，2025 年至 2032 年

市場調查報告書

商品編碼

1775649

動脈切開封堵器市場規模、佔有率、成長分析（按產品、應用、最終用戶、地區）- 產業預測，2025 年至 2032 年

Arteriotomy Closure Devices Market Size, Share, and Growth Analysis, By Product, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年07月18日 | 出版商:

SkyQuest | 英文 198 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球動脈切開封堵器市場規模為 18 億美元，預計將從 2024 年的 19.4 億美元成長到 2032 年的 34.5 億美元，預測期內（2025-2032 年）的複合年成長率為 7.5%。

全球動脈切開封堵器市場正經歷強勁成長，這得益於心血管疾病盛行率的上升，心血管疾病是全球最大的死亡原因。血管成形術和冠狀動脈導管插入術等介入性手術的興起，推動了對可靠封堵解決方案的需求，尤其是在進行此類手術的醫院。儘管對傳統醫院的依賴依然存在，但門診血管手術以其更低的成本和更快的恢復時間而具有吸引力，使得此類手術在門診手術中心的應用顯著增加。然而，在中低收入國家，先進封堵技術的可及性有限，因此仍面臨挑戰。市場參與企業正在透過地理擴張、價格可負擔性提升和有針對性的培訓計劃來應對這些挑戰，從而增強市場的成長軌跡。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益同比對比（2022-2024 年）

主要企業簡介

Abbott Laboratories
Terumo Corporation
Cardinal Health（Cordis）
Boston Scientific Corporation
Medtronic plc
Teleflex Incorporated（Vascular Solutions）
Vivasure Medical Ltd.
TZ Medical, Inc.
Meril Life Sciences Pvt. Ltd.
Morris Innovative, Inc.

結論和建議

簡介目錄

Product Code: SQMIG35A3072

Global Arteriotomy Closure Devices Market size was valued at USD 1.8 billion in 2023 and is poised to grow from USD 1.94 billion in 2024 to USD 3.45 billion by 2032, growing at a CAGR of 7.5% during the forecast period (2025-2032).

The global market for arteriotomy closure devices is witnessing robust growth, spurred by the escalating prevalence of cardiovascular diseases, which are a primary cause of mortality worldwide. The increasing number of interventional procedures such as angioplasty and coronary catheterization has amplified the need for reliable closure solutions, particularly within hospitals where most such treatments occur. While traditional reliance on hospitals persists, there is a notable uptick in adoption within ambulatory surgical centers due to the appeal of outpatient vascular procedures that offer cost savings and quicker recovery times. However, challenges remain in low- and middle-income countries, where access to advanced closure technologies is limited. Market players are addressing these challenges through geographic expansion, enhanced affordability, and targeted training initiatives, thereby reinforcing the market's growth trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Arteriotomy Closure Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Arteriotomy Closure Devices Market Segments Analysis

Global Arteriotomy Closure Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Active Closure Devices and Passive Closure Devices. Based on Application, the market is segmented into Femoral Arterial Access Procedures and Radial Arterial Access Procedures. Based on End User, the market is segmented into Hospitals, Ambulatory Care Centers and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Arteriotomy Closure Devices Market

The increasing prevalence of interventional procedures such as coronary angiography, percutaneous coronary intervention (PCI), transcatheter aortic valve replacement (TAVR), and peripheral artery interventions is driving the demand for arteriotomy closure devices. As the number of these procedures rises, the need for efficient hemostasis, shorter recovery times, and a decrease in complications, such as hematomas and excessive bleeding, becomes more critical. Consequently, vascular closure devices have become essential components in providing care following femoral and radial access catheterizations. This growing trend underscores the importance of innovative solutions in the global arteriotomy closure devices market.

Restraints in the Global Arteriotomy Closure Devices Market

A significant barrier to the widespread adoption of arteriotomy closure devices, particularly in developing economies, is their high cost. While manual compression methods are more affordable, healthcare institutions in budget-restricted regions face challenges due to limited reimbursement options, price-sensitive procurement strategies, and inadequate infrastructure to support advanced technologies. As a result, many hospitals in emerging markets, such as those in Southeast Asia and Latin America, continue to rely on manual closure techniques because the newer devices are financially unfeasible. This situation underscores the need for more accessible solutions that can facilitate greater integration of advanced closure systems in these settings.

Market Trends of the Global Arteriotomy Closure Devices Market

The Global Arteriotomy Closure Devices market is experiencing a significant trend towards the adoption of minimally invasive and large-bore interventions, driven by an increased preference for efficient vascular closure solutions that enhance patient outcomes. With the rapid proliferation of procedures like TAVR and EVAR in both developed and emerging markets, the demand for advanced closure devices is on the rise. Innovations such as Abbott's latest iteration of the Perclose ProStyle system, launched in early 2025, cater specifically to high-volume catheterization labs, offering faster deployment and improved control to mitigate operator variability and reduce post-operative complications. This trend underscores a shift towards more effective and patient-friendly surgical solutions in the cardiovascular landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Case Studies
Customer Buying Behavior Analysis

Global Arteriotomy Closure Devices Market Size by Product & CAGR (2025-2032)

Market Overview
Active Closure Devices
Passive Closure Devices

Global Arteriotomy Closure Devices Market Size by Application & CAGR (2025-2032)

Market Overview
Femoral Arterial Access Procedures
Radial Arterial Access Procedures

Global Arteriotomy Closure Devices Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Ambulatory Care Centers
Other

Global Arteriotomy Closure Devices Market Size & CAGR (2025-2032)

North America (Product, Application, End User)
- US
- Canada
Europe (Product, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (Cordis)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (Vascular Solutions)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vivasure Medical Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TZ Medical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Morris Innovative, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments